TetraGraph Neuromuscular Transmission Monitor (SEN 2015)Accessories:TetraSens (SEN 2012)TetraSens Pediatric (SEN 2013)TetraSensitive (SEN 2016)TetraHub (SEN 2017)
Senzime AB · Decision date May 22, 2026
What did the FDA decide?
FDA records K261098 as a 510(k) premarket notification, with a decision dated May 22, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Anesthesiology
- Decision date
- May 22, 2026
Regulatory record facts
- Identifier
- K261098
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Senzime AB
- Product code
- KOI
- Decision code
- SESE
- Decision date
- May 22, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, Nerve, Peripheral, Electric.
- Applicant
- Senzime AB
- Product code
- KOI
- FDA device class
- 2
FDA decision timeline
K261098 received
Application receipt date recorded by FDA.
K261098 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Senzime AB
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Uppsala
Sources and methodology
- Original FDA record: K261098
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records